Windward Bio raised $200M in a Series A funding round led by OrbiMed Novo Holdings and Blue Owl Healthcare Opportunities to develop a phase 2-ready monoclonal antibody for asthma and COPD.
Amount Raised
$200 Million
Round Type
Series A
BaselBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Windward Bio officially launched with $200 million in Series A financing. The funding will support the development of its lead program, a long-acting anti-TSLP monoclonal antibody, and additional discovery pipeline for bispecifics.
Quick answer
Windward Bio raised $200 Million in a Series A round, dated January 10, 2025. Investors: Pivotal bioVenture Partners, OrbiMed Novo Holdings, SR One, Quan Capital and Blue Owl Healthcare Opportunities. Windward Bio is based in Basel, Basel City, Switzerland.
- How much did Windward Bio raise?
- Windward Bio raised $200 Million in a Series A round on January 10, 2025.
- Who invested in Windward Bio?
- Pivotal bioVenture Partners, OrbiMed Novo Holdings, SR One, Quan Capital and Blue Owl Healthcare Opportunities are named as investors in this round.
- What does Windward Bio do?
- Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions.
- Where is Windward Bio based and how big is it?
- Windward Bio is based in Basel, Basel City, Switzerland. Fundz records about 40 employees.
- Who are the decision-makers at Windward Bio?
- Fundz holds 2 contacts at Windward Bio, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Windward Bio that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $15M on February 10, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Os Therapies raised $7.1M on December 31, 2024.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
Who to call at Windward Bio, and when
A new round usually means Windward Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Windward Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Windward Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Windward Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Windward Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWindward Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.